tiprankstipranks
H&R GmbH & Co. KGaA (GB:0RRC)
LSE:0RRC

H&R GmbH & Co. KGaA (0RRC) Share Price & Analysis

0 Followers

0RRC Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€4.30 - €5.50
Previous Close€4.9
Volume2.00
Average Volume (3M)1.51K
Market Cap
€182.76M
Enterprise Value€362.95M
Total Cash (Recent Filing)€73.60M
Total Debt (Recent Filing)€203.24M
Price to Earnings (P/E)14.0
Beta0.50
May 15, 2024
EPS EstimateN/A
Dividend Yield2.04%
Share Statistics
EPS (TTM)0.35
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. Volume1,510
Standard Deviation0.11
R-Squared0.27
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.00%0.79%0.03%99.18%
0.00%
Insiders
0.03% Other Institutional Investors
99.18% Public Companies and
Individual Investors

0RRC FAQ

What was H&R GmbH & Co. KGaA’s price range in the past 12 months?
H&R GmbH & Co. KGaA lowest share price was €4.30 and its highest was €5.50 in the past 12 months.
    What is H&R GmbH & Co. KGaA’s market cap?
    Currently, no data Available
    When is H&R GmbH & Co. KGaA’s upcoming earnings report date?
    H&R GmbH & Co. KGaA’s upcoming earnings report date is May 15, 2024 which is in 8 days.
      How were H&R GmbH & Co. KGaA’s earnings last quarter?
      H&R GmbH & Co. KGaA released its earnings results on Mar 28, 2024. The company reported -€0.02 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.02.
        Is H&R GmbH & Co. KGaA overvalued?
        According to Wall Street analysts H&R GmbH & Co. KGaA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does H&R GmbH & Co. KGaA pay dividends?
          H&R GmbH & Co. KGaA pays a Annually dividend of €0.1 which represents an annual dividend yield of 2.04%. See more information on H&R GmbH & Co. KGaA dividends here
            What is H&R GmbH & Co. KGaA’s EPS estimate?
            H&R GmbH & Co. KGaA’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does H&R GmbH & Co. KGaA have?
            H&R GmbH & Co. KGaA has 37,221,745 shares outstanding.
              What happened to H&R GmbH & Co. KGaA’s price movement after its last earnings report?
              H&R GmbH & Co. KGaA reported an EPS of -€0.02 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.202%.
                Which hedge fund is a major shareholder of H&R GmbH & Co. KGaA?
                Currently, no hedge funds are holding shares in GB:0RRC
                ---

                H&R GmbH & Co. KGaA Stock Smart Score

                5
                Neutral
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Fundamentals

                Return on Equity
                2.97%
                Trailing 12-Months
                Asset Growth
                3.41%
                Trailing 12-Months

                Company Description

                H&R GmbH & Co. KGaA

                H&R GmbH & Co KGaA is a manufacturer of chemical-pharmaceutical specialty products. It operates in three main business segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment produces specialty products from crude oil in the two domestic refineries (Hamburg-Neuhof and Salzbergen). Its ChemPharm Sales segment encompasses the production sites abroad as well as international sales activities. The company's Plastic segment manufactures high-precision plastic parts along with the associated tools and molds. The company derives the majority of its revenue from the ChemPharm Refining segment within Germany.
                ---
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis